Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddelte i dag, at bestyrelsesformand Steen Riisgaard har meddelt bestyrelsen, at han ønsker at fratræde på selskabets ordinære generalforsamling i marts...
-
ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that Steen Riisgaard, ALK’s Chairman of the Board, has informed the Board of Directors of his intention to step down at the company's next...
-
ALK’s new tree SLIT-tablet, ITULAZAX®, has been launched in its first market: GermanyTree pollen allergy is highly prevalent in northern Europe, making Germany a key market for the productIn trials,...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) indberetter hermed følgende transaktioner: 1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til dennea)NavnHenrik...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions: 1.Details of the person discharging managerial responsibility / person closely associateda)NameHenrik...
-
Bemærk venligst, at rapporten udelukkende findes på engelsk. Upgraded financial outlook and on track to deliver double-digit growth (unaudited)In Q2, ALK continued to deliver on its strategy, with...
-
Upgraded financial outlook and on track to deliver double-digit growth (unaudited) In Q2, ALK continued to deliver on its strategy, with broad-based growth across all regions and further strong...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddelte i dag, at virksomheden opjusterer forventningerne til regnskabsåret 2019 baseret på et bedre end forventet resultat for første halvår samt...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the company has revised its 2019 financial guidance upwards based on the better than expected results in the first...
-
ALK's (ALKB:DC / OMX: ALK B / AKABY / AKBLF) nye anafylaksi-strategi er at blive en betydelig aktør på det amerikanske adrenalinmarked baseret på en eksklusivaftale med Windgap Medical om lancering af...